Technologies for personalised cancer immunotherapies
Technologies for personalised cancer immunotherapies
Clinical cases employing novel agents in Hodgkin lymphoma
Current trials in chronic lymphocytic leukaemia
Multi-target S-DNA increases colorectal cancer screening among previously non-compliant patients
Combination therapy before surgery improves outcomes for patients with HER2 positive breast cancer
New technology can potentially overcome CAR T-cell limitations
The future of haematopathology
MINDACT breast cancer clinical trial: First results and impact on future trial design
BSH 2016: Expert discussion on front line care in CLL
SPF30 sunscreens delay melanoma incidence in preclinical model
WIN 2016: Preview of themes
Fundamental developments in palliative care